Pittman Scott M. has filed 17 insider transactions across 1 company since August 2018.
Most recent transaction: a grant/award of 2050 shares of Nuo Therapeutics, Inc. ($AURX) on January 23, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Commitment Warrants (right to buy) | 2050 | $1.50 | 0.0000 | 48,077,745 | 0.00% | 0.00% |
| Jan. 23, 2026 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Prepayment Warrants (right to buy) | 7516 | $1.50 | 0.0000 | 48,077,745 | 0.00% | 0.02% |
| Jan. 23, 2026 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Capital Second Warrants (right to buy) | 35000 | $1.50 | 0.0000 | 48,077,745 | 0.00% | 0.07% |
| Jan. 23, 2026 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Origination Second Warrants (right to buy) | 1750 | $1.50 | 0.0000 | 48,077,745 | 0.00% | 0.00% |
| Jan. 23, 2026 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Capital Initial Warrants (right to buy) | 26667 | $1.50 | 0.0000 | 48,077,745 | 0.00% | 0.06% |
| Jan. 23, 2026 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Origination Initial Warrants (right to buy) | 1333 | $1.50 | 0.0000 | 48,077,745 | 0.00% | 0.00% |
| July 30, 2025 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Common Stock | 3946 | $1.50 | 5,400,000.0000 | 46,816,114 | 0.07% | 0.01% |
| Nov. 15, 2024 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | M | Common Stock | 121875 | $0.40 | 5,300,220.0000 | 0 | 2.35% | 0.00% |
| Dec. 31, 2018 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | M | Option to Purchase Common Stock | 62500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 9, 2018 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | M | Option to Purchase Common Stock | 121875 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 15, 2024 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | M | Common Stock | 33334 | $0.50 | 5,396,054.0000 | 0 | 0.62% | 0.00% |
| Nov. 15, 2024 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | M | Common Stock | 62500 | $0.40 | 5,362,720.0000 | 0 | 1.18% | 0.00% |
| March 4, 2022 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | M | Option to Purchase Common Stock | 33334 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| July 17, 2024 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Option to Purchase Common Stock | 40000 | $0.33 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Common Stock | 135000 | $0.75 | 5,178,345.0000 | 0 | 2.68% | 0.00% |
| Dec. 19, 2023 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Common Stock | 600000 | $0.50 | 5,043,345.0000 | 0 | 13.50% | 0.00% |
| Aug. 1, 2023 | Nuo Therapeutics, Inc. | $AURX | Pittman Scott M. | Director | A | Common Stock | 100000 | $2.00 | 4,443,345.0000 | 0 | 2.30% | 0.00% |